Medication Safety in Pregnancy

• Home
• What is EUROmediCAT?
• Data
• Research
• ConcePTION
• EUROmediSAFE
• FP7 EUROmediCAT
• Organisation
• Advisory Board
• Objectives
• WP1 Coordination and Management
• WP2 Central Database and Software Development
• WP3 Prescription Data Linkage
• WP4 Antiepileptic Drugs and Insulin Analogues
• WP5 SSRIs and Anti-asthmatics
• WP6 Monitoring of Safety Recommendations: Drug Utilisation Studies
• WP7 Implications of the Internet in Relation to Medication Access and Safety Information
• WP8 Dissemination Workshop
• Other Research
• How to Propose or Commission Specific Studies
• Publications and Presentations
• Partners
• Useful Links
• Contact Information

Where Am I? -> Research -> FP7 EUROmediCAT
Direct link to this page: http://www.EUROmediCAT.eu/research/fp7euromedicat

FP7 EUROmediCAT

 

EUROmediCAT was funded by an EU FP7 grant from 2011 - 2015.  This part of the website refers to the activities that were carried out during this time period.

 

Organisation

Advisory Board

Objectives

WP1 Coordination and Management

WP2 Central Database and Software Development

WP3 Prescription Data Linkage

WP4 Antiepileptic Drugs and Insulin Analogues

WP5 SSRIs and Anti-asthmatics

WP6 Montioring of Safety Recommendations: Drug Utilisation Studies

WP7 Implications of the Internet in Relation to Medication Access and Safety information

WP8 Dissemination Workshop

 

EUROmediCAT is a project funded under the European Union's 7th Framework Programme
© EUROmediCAT, 2011